Assignee
HALLAHAN DENNIS E
US·9 granted patents·3 pending applications·70 citations·filing 2003–2016
Top patents by PatentIndex Score
12 records- 0194US8101157B2Ligands to radiation-induced moleculesHALLAHAN DENNIS E·Filed 2006·Granted Jan 24, 2012·13 cites·14 claims
- 0293US8388932B2Ligands to radiation-induced moleculesHALLAHAN DENNIS E·Filed 2011·Granted Mar 5, 2013·11 cites·17 claims
- 0392US8771754B2Use of GSK3 inhibitors in combination with radiation therapiesHALLAHAN DENNIS E·Filed 2005·Granted Jul 8, 2014·23 cites·35 claims
- 0492US8765097B2Ligands to radiation-induced moleculesHALLAHAN DENNIS E·Filed 2013·Granted Jul 1, 2014·8 cites·17 claims
- 0591US9340581B2Ligands to radiation-induced moleculesHALLAHAN DENNIS E·Filed 2014·Granted May 17, 2016·6 cites·13 claims
- 0687US10086073B2Ligands to radiation-induced moleculesHALLAHAN DENNIS E·Filed 2016·Granted Oct 2, 2018·2 cites·13 claims
- 0777US8617521B2Phage antibodies to radiation-inducible neoantigensHALLAHAN DENNIS E·Filed 2011·Granted Dec 31, 2013·7 cites·8 claims
- 0860US8129356B2Bmx mediated signal transduction in irradiated vascular endotheliumHALLAHAN DENNIS E·Filed 2008·Granted Mar 6, 2012·0 cites·37 claims
- 0956US2012089017A1Ligands to radiation-induced moleculesHALLAHAN DENNIS E·Filed 2011·Application pending·0 cites
- 1053US2006084697A1Pi3k antagonists as radiosensitizersHALLAHAN DENNIS E·Filed 2003·Application pending·0 cites
- 1152US8740762B2Specific inhibition of cPLA2 enhances the efficacy of radiotherapyHALLAHAN DENNIS E·Filed 2008·Granted Jun 3, 2014·0 cites·34 claims
- 1243US2010135905A1Assessment of cancer susceptibility to molecular targeted therapy by use of recombinant peptidesHALLAHAN DENNIS E·Filed 2010·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →